Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.38 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 4/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27758758 | 0.98 | MMP1 (0.43) | MMP1MMP3MMP8ANPEPALDH1A1 | |
| SCHEMBL329844 | 0.86 | MMP1 (0.45) | MMP1MMP3MMP8ANPEPCA12 | |
| SCHEMBL29071032 | 0.83 | MMP1 (0.39) | MMP1MMP3MMP8ANPEPL3MBTL1 | |
| SCHEMBL1615661 | 0.82 | MMP1 (0.42) | MMP1MMP3MMP8ANPEPCA12 | |
| SCHEMBL20473220 | 0.82 | MMP1 (0.42) | MMP1MMP3MMP8ANPEPCA12 | |
| SCHEMBL8763211 | 0.82 | — | — | |
| SCHEMBL7116797 | 0.81 | MMP1 (0.35) | MMP1MMP3MMP8ANPEPALDH1A1 | |
| SCHEMBL21145497 | 0.80 | MMP1 (0.41) | MMP1MMP3MMP8ANPEPCA12 | |
| SCHEMBL4302310 | 0.80 | MMP1 (0.38) | MMP1MMP3MMP8ANPEPALDH1A1 | |
| SCHEMBL20580622 | 0.80 | MMP1 (0.37) | MMP1MMP3MMP8ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118591391-A | Muscle targeting complexes and their use for the treatment of myodystrophy | 达因疗法公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118510898-A | Muscle targeting complexes and their use for the treatment of myodystrophy | 达因疗法公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118450896-A | Muscle targeting complexes and their use for the treatment of myodystrophy | 达因疗法公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118401553-A | Muscle targeting complexes and their use for the treatment of myodystrophy | 达因疗法公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118355035-A | Muscle targeting complexes and their use for the treatment of myodystrophy | 达因疗法公司 | 2024-07-16 | — | — | CN | claimed |
| CN-118207212-A | Antisense nucleic acid | 日本新药株式会社 | 2024-06-18 | — | — | CN | claimed |
| CN-118201640-A | Muscle targeting complexes for the treatment of myodystrophy | 达因疗法公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117980006-A | Muscle targeting complexes and formulations for the treatment of myodystrophy | 达因疗法公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117721110-A | Antisense nucleic acid | 日本新药株式会社 | 2024-03-19 | — | — | CN | claimed |
| CN-117202937-A | Construction method and application of nucleic acid self-assembly mediated ADC (analog to digital converter) drug | 安升（上海）医药科技有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116368150-A | Muscle targeting complexes and their use for the treatment of myodystrophy | 达因疗法公司 | 2023-06-30 | — | — | CN | claimed |
| WO-2022206881-A1 | METHOD FOR CONSTRUCTION OF NUCLEIC ACID SELF-ASSEMBLY-MEDIATED ADC DRUG AND USE THEREOF | 安升（上海）医药科技有限公司 | 2022-10-06 | — | — | WO | claimed |
| EP-3822259-A1 | METHOD FOR SYNTHESIZING VALSARTAN | Zhejiang Huahai Pharmaceutical Co., Ltd. (CN) | 2021-05-19 | — | — | EP | claimed |
| CN-111630167-A | Antisense oligonucleotides for modulating T cell function | 新加坡科技研究局 | 2020-09-04 | — | — | CN | claimed |
| CN-110114464-A | Method by targeting the antisense strategy cancer of PRDM15 | 新加坡科技研究局 | 2019-08-09 | — | — | CN | claimed |
| CN-109490519-A | A kind of leukocyte esterase Test paper and preparation method thereof | 迪瑞医疗科技股份有限公司 | 2019-03-19 | — | — | CN | claimed |
| CN-105805426-B | Pipeline runs through device | 上海火克新材料有限公司 | 2017-10-27 | — | — | CN | claimed |
| EP-2077912-A1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | The President and Fellows of Harvard College (US) | 2009-07-15 | — | — | EP | claimed |
| CN-101213203-A | Methods and compositions for regulating expression of nucleic acids at post-transcriptional level | UNIV NORTH CAROLINA (US) | 2008-07-02 | — | — | CN | claimed |
| WO-2008021123-A1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-02-21 | — | — | WO | claimed |